Sami Koskelainen
Impact in
- Genetics top 5%
- Genetic Associations and Epidemiology
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Genetics 7
- Genetic Associations and Epidemiology 4
- BRCA gene mutations in cancer 3
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 2
Sami Koskelainen
25 papers receiving 3.9k citations
Sami Koskelainen's Hit Papers
Peers
Comparison fields: 5 of 123
- Genetics 850
- Infectious Diseases 526
- Immunology 407
- Obstetrics and Gynecology 133
- Biological Psychiatry 29
Countries citing papers authored by Sami Koskelainen
This map shows the geographic impact of Sami Koskelainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami Koskelainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami Koskelainen more than expected).
Fields of papers citing papers by Sami Koskelainen
This network shows the impact of papers produced by Sami Koskelainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami Koskelainen. The network helps show where Sami Koskelainen may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FinnGen provides genetic insights from a well-phenotyped isolated population Hit paper breakdown → | 2023 | 2455 |
| 2 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 3 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 4 | 2021 | 134 | |
| 5 | 2022 | 107 | |
| 6 | Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy Hit paper breakdown → | 2023 | 80 |
| 7 | 2023 | 56 | |
| 8 | 2023 | 39 | |
| 9 | 2021 | 32 | |
| 10 | 2022 | 30 | |
| 11 | 2024 | 19 | |
| 12 | 2023 | 16 | |
| 13 | 2023 | 15 | |
| 14 | 2023 | 15 | |
| 15 | 2022 | 13 | |
| 16 | 2023 | 13 | |
| 17 | 2023 | 9 | |
| 18 | 2024 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 5 |
About Sami Koskelainen
Sami Koskelainen is a scholar working on Genetics, Infectious Diseases, Immunology, Experimental and Cognitive Psychology and Obstetrics and Gynecology, having authored 25 papers that have together received 3.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Genetic Associations and Epidemiology (4 papers), interferon and immune responses (3 papers), Sleep and related disorders (3 papers), BRCA gene mutations in cancer (3 papers), COVID-19 Clinical Research Studies (2 papers), Chronic Disease Management Strategies (2 papers) and Sleep and Wakefulness Research (2 papers). The work is most often cited by research in Genetics (850 citations), Infectious Diseases (526 citations), Immunology (407 citations), Obstetrics and Gynecology (133 citations) and Biological Psychiatry (29 citations). Sami Koskelainen has collaborated with scholars based in Finland, United States and United Kingdom. Their work appears in journals such as Nature, Nature Communications, Communications Biology, Scientific Reports and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.